Human Recombinant IFN-A 2A (from E. coli)
Proveedor: Shenandoah Biotechnology
100-54-100UG
100-54-1MG
100-54-20UG
100-54-250UG
100-54-500UG
SHBT100-54-100UGEA
181
EUR
SHBT100-54-100UG
SHBT100-54-1MG
SHBT100-54-20UG
SHBT100-54-250UG
SHBT100-54-500UG
Human Recombinant IFN-A 2A (from E. coli)
Proteínas y Péptidos
Interferon-alpha 2a (IFN-α 2a) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2a. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2a variant differs from IFN-α 2b by one amino acid.
- High quality
- Low endotoxin
- Affordable
Precaución: For research use only.
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...